Table 1 Demographic, clinical and serological features from patients and controls
NMO spectrum disorders | Controls | |||||
|---|---|---|---|---|---|---|
NMO (n = 24) | LETM (n = 24) | ON (n = 13) | Myelitis (n = 3) | MS (n = 17) | HS (n = 10) | |
Gender (F/M) | 21/3 | 17/7 | 8/5 | 3/0 | 13/4 | 7/3 |
Mean age (range) | 50 (29–78) | 51 (4–78) | 39 (13–55) | 52 (46–58) | 38.4 (11–77) | 39.5 (26–57) |
AQP4-Ab (ELISA) | ||||||
Median (U/mL) range | 27.9 (1.5–464) | 1.5 (1.5–214.5) | 1.5 (1.5–1.9) | 1.5 (1.5–3.1) | 1.5 (1.5–1.85) | 1.5 (1.5–2.1) |
Frequency (%) | 20/24 (83.3%) | 6/24 (25%) | 0/13 (0%) | 1/3 (33.3%) | 0/17(0%) | 0/10 (0%) |